|
Volumn 40, Issue 5, 2001, Pages 566-573
|
A Swedish study of chemoradiation in squamous cell carcinoma of the esophagus
a a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CHEMOTHERAPY;
PATIENT TREATMENT;
RADIOTHERAPY;
TOXICITY;
CHEMORADIATION;
ONCOLOGY;
ANTINEOPLASTIC AGENT;
CISPLATIN;
FLUOROURACIL;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
ARTICLE;
BLOOD TOXICITY;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CARDIOTOXICITY;
DIARRHEA;
ESOPHAGUS CARCINOMA;
ESOPHAGUS RESECTION;
FOLLOW UP;
HUMAN;
INFECTION;
LEUKOPENIA;
MAJOR CLINICAL STUDY;
MORTALITY;
MUCOSA INFLAMMATION;
NAUSEA;
NEPHROTOXICITY;
OTOTOXICITY;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
RADIATION DOSE;
SEPTICEMIA;
SQUAMOUS CELL CARCINOMA;
SWEDEN;
TREATMENT PLANNING;
VOMITING;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, SQUAMOUS CELL;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
COMBINED MODALITY THERAPY;
DISEASE-FREE SURVIVAL;
DOSE FRACTIONATION;
ESOPHAGEAL NEOPLASMS;
ESOPHAGECTOMY;
FEMALE;
FILGRASTIM;
FLUOROURACIL;
GASTROINTESTINAL DISEASES;
HEART DISEASES;
HEMATOLOGIC DISEASES;
HUMANS;
LIFE TABLES;
MALE;
MIDDLE AGED;
RADIOTHERAPY, ADJUVANT;
SURVIVAL ANALYSIS;
SWEDEN;
TREATMENT OUTCOME;
|
EID: 0034789236
PISSN: 0284186X
EISSN: None
Source Type: Journal
DOI: 10.1080/028418601750444097 Document Type: Article |
Times cited : (22)
|
References (28)
|